INTRODUCTION
H ereditary spastic paraplegia (HSP) are a group of neurodegenerative or neurodevelopmental disorders of clinically and genetically heterogeneous nature. The most established pathomechanism of neurodegeneration involves the progressive distal axonopathy of the longest motor fibers that encompasses the corticospinal tract and posterior column (Klebe et al., 2015) . The distinguishing neurological and clinical feature is the spasticity of the lower limbs, weakness and hyperreflexia. However, HSP patients present a variety of neurological and nonneurological symptoms (Blackstone et al., 2011; Parodi et al., 2017) . This disorder is classified into pure and complex forms, depending on the clinical features they present. Pure HSP form includes lower limb spasticity, which is sometimes accompanied with bladder spasticity and hyperreflexia, while complex HSP exhibits other associated neurological and non-neurological features such as seizures, amyotrophy, ataxia, cognitive impairment, deafness, ophthalmic dysfunction, facial deformities, orthopedic abnormalities, and digestive reflux.
A number of molecular mechanisms such as abnormal intracellular trafficking, disturbed organelle morphogenesis, axonal transport dysfunction, lipid metabolism disturbance, mitochondrial dysfunction and dysregulated pigmentation are proposed to be implicated in pathogenicity of the disease (Salinas et al., 2008; Nagle et al., 1996) . To date, 59 causative genes (https:// www.ncbi.nlm.nih.gov/books/NBK1509/) have been identified involving all mode of inheritance. These include autosomal dominant, autosomal recessive, X-linked and maternal mitochondrial transmission (Giudice et al., 2014; Finsterer et al., 2012) .
Bicaudal D, Drosophila homologue 2 (BICD2) has been identified as causative gene of autosomal dominant spinal muscular atrophy with lower extremity predominance 2 (SMALED2) and hereditary spastic paraplegia (HSP) (Synofzik et al., 2014; Neveling et al., 2013; Oates et al., 2013; Peeters et al., 2013; Rossor et al., 2015) . BICD2 regulates the trafficking of key cellular cargoes like mRNA, Golgi, and secretary vesicles by interacting with dynein-dynactin complex and small GTPase RAB6. A flawless retrograde and anterograde transport along microtubules is very crucial for motor neuron development and functional integrity (Matanis et al., 2002; Hoongenraad et al., 2001) .
A B S T R A C T

O n l i n e F i r s t A r t i c l e
In this study, we report a family of congenital onset, complex hereditary spastic paraplegia with autosomal recessive mode of inheritance. We identified a protein truncation mutation in BICD2 after whole exome sequencing (WES) and Sanger sequencing techniques.
MATERIALS AND METHODS
Study material
This study was commenced with the approval from bioethics committee of University of the Punjab. Lahore. Informed consent was obtained from the patient's parents. A family with two affected individuals (V-1 and V-2) presenting hereditary spastic paraplegia of complex type and severe microcephaly was ascertained from region of north-eastern Pakistan to explore the cause of the disorder. Blood samples from two affected and six unaffected individuals were obtained in ethylenediaminetetra acetic acid (EDTA) containing BD vacutainers® (BD-Plymouth, UK). Genomic DNA was extracted using salting out method (Helms, 1990) .
Linkage analysis
Genomic DNA from four individuals (two affected and the parents) were submitted for genome-wide linkage analysis using the Axiom Precision Medicine Research Array from Affymetrix (Santa Clara, CA). LOD score was calculated with the reduced marker panels of 25K and 100K using programme ALLEGRO (Gudbjartsson et al., 2000) . Linkage analysis was performed assuming autosomal recessive mode of inheritance, full penetrance, consanguinity and allele frequency of 0.0001. Mendelian errors were detected using PedCheck (O'Connell and Weeks, 1998) .
Whole exome sequencing
Whole exome sequencing of one affected individual (V-1) was performed using the Agilent (Santa Clara, CA) version 6 enrichment kit and the Illumina HiSeq 4000 sequencing system (paired-end reads, 2x75bp). The exome data was filtered and analysed using Cologne Center for Genomics in house database VARBANK (http:// varbank.ccg.uni-koeln.de) as described (Szczepanski et al., 2016) . Exome data was also explored for variants in causative genes of other clinical symptoms exhibited by patients like microcephaly, hearing loss, intellectual disability and speech impairment. Variant prioritization was done with relation to phenotype using wANNOVAR (http://wannovar.wglab.org) and Phenolyzer (http:// phenolyzer.wglab.org).The prioritized variants were analysed using bioinformatic tools for pathogenicity prediction.
Co-seggregation analysis
A variant identified in BICD2 as possible cause of disease phenotype was validated for co-segregation using Sanger sequencing. Sequencing primers (Forward primer: 5'-TCGAGGAGAAGCACCAGCTCAAG-3'; Reverse primer:
5'-CTGCATTAGCGGCGTCTGCAAC-3') were designed using Primer 3 software (https://bioinfo. ut.ee/primer3-0.4.0/primer3/). BigDye ® Terminator v1.1 Cycle sequencing kit (Applied Biosystem) was used for sequencing of amplified PCR product on ABI 3730 genetic analyzer (Applied Biosystem). Sequencing data was analysed on DNA Star (Lasergene).
RESULTS
Patients
Two affected individuals were born to the normal parents who were second cousins. Analysis of pedigree ( Fig. 1A) confirmed an autosomal recessive mode of inheritance. Both patients were reported to be affected by birth. Patient V-1 was a 3 years old female at the time of examination and her brother (V-2) was 1.5 years old ( Fig. 1B) . Birth of both affected individuals was after full term pregnancy and without complication. Both patients exhibited clinical features of hereditary spastic paraplegia with spasticity and stiffness of lower as well as upper limbs and severe microcephaly with reduced head circumference of -10 and -11 SD. Both patients presented hearing impairment, no speech, dystonia, dysphagia and seizures. They often had screaming bouts. They could not sit or stand. Individual V-1 has normal height of 91.4cm while the boy V-2 had slightly short stature of 73.6 cm (-2.5 SD).
Mutation identification
Genome wide linkage analysis using 25K panel resulted in two peak areas reaching the theoretical maximum LOD score of 2.4 on chromosome 5 and 9 while two additional peaks at chromosome 6 and 19 were obtained with panel of 100K markers (Fig. 2) . Position of homozygous linkage region were as follows: #5a, rs316574 (0-2304811 bp); #5b, rs10062024-rs142796294 (3710645-4423695 bp); #5c, rs379181-rs6873433 (5752026-6596404 bp); #5d, rs2860357-rs13175954 (10950177-11723594 bp); #6, rs2235233-rs3130814 (27279852-29196181); #9, rs73654026-rs2487912 (94438287-100882881 bp): #19a, rs35029254-rs17676218 (4874019-5288875 bp) and #19b, rs67507307-rs11671501 (13429114-14707030 bp) with cytoband 5p15.33 (2.3Mb), 5p15.33 (0.71Mb), 5p15.32-p15.31 (0.84Mb), 5p15.2 (0.77Mb), 6p22.1 (1.92Mb), 9q22.31-q22.33 (6.44Mb), 19p13.3 (0.41Mb) and 19p13.2-p13.12 (1.28Mb).
O n l i n e F i r s t A r t i c l e
Exome sequencing data was filtered and scrutinized for causative variants by setting the minimal allele frequency to <0.01. This revealed a nonsense mutation in BICD2 (NM_001003800.1; c.204T>G) which was located on chromosome 9 linkage region 9q22. . This variant in exon 1 changes a glutamic acid codon into a premature stop codon (p. Glu68*) (Fig.3A, 3B) and thus, was predicted to result in a severely truncated protein, if translated. Mutation taster (http://www.mutationtaster. org/) and CADD score (https://cadd.gs.washington. edu/score) predicted it to be pathogenic. This variant of BICD2 was not found in databases like dbSNP150, 1000 Genomes (build 20110521), in-house database at Cologne Center for Genomics with >1,600 exomes, ExAC (http:// exac.broadinstitute.org/), and gnomAD (https://gnomad. broadinstitute.org/). 
Segregation analysis
Targeted Sanger sequencing results showed that this variant segregated with the phenotype in the expected autosomal recessive mode of inheritance, as all affected individuals were homozygous and carriers were heterozygous (Fig. 3C ). Fig. 2 . Genome-wide scans for homozygous regions using 100K marker panel and multipoint LOD score graphs generated with ALLEGRO. Linkage region on chromosome 9 harboring BICD2 is indicated.
DISCUSSION
We have identified a novel protein truncation mutation in BICD2. Human BICD2 (OMIM 609797) is a homologue of Drosophila bicaudal D (BicD). It encodes a ubiquitously expressed translational product of 96kDa. BICD2 is a motor-adaptor protein that links the dynein motor complex to various cargoes. Five coiled coil regions constitute this highly conserved protein. The N-terminal CC1 domain interacts with dynein-dynactin complex, C-terminal CC3 domain links to RAB6A that localizes to Golgi apparatus and cytoplasmic vesicles while central CC2 domain binds to a kinesin KIF5A (Fig. 3B ) (Matanis et al., 2002) . It is proposed that when C-terminal region binds to the cargo, the N-terminal part becomes available to bind to dynein and induces minus end directed transport (Hoongenraad et al., 2001) . Intramolecular interactions between N-termninal and C-terminal domain were also demonstrated by Hoongenraad and colleagues suggesting that they have regulatory feature in accurate cellular trafficking by BICD2. So far, 25 mutations have been reported in BICD2 encompassing the entire coding sequence generating a spectrum of motor neuron ailments O n l i n e (Novarino et al., 2014) . The homozygous mutation in our family (c.204T>G) causes the insertion of a premature stop codon in the open reading frame, predicted to results in a truncated protein of 68 amino acids (p.Glu68*). This nonsense mutation disrupts the first coiled coil domain depleting most of the protein. It is highly probable that the variant results in nonsense-mediated decay of mRNA and ultimately complete loss of protein. Phenotypic features presented by affected kindred of HSP family reported by Oats et al., 2013 were the lower limb spasticity and hyperreflexia. Contractures, weakness and wasting of muscles were progressive and less severe. Members of our family had upper and lower limbs spasticity, dysphagia, cognitive impairment and seizures episodes. Patients were bed ridden. They presented severe microcephaly with hearing and speech impairment. Bicd2 knockout mice developed disorganized cerebral cortex and the cerebellum due to impaired radial neuronal migration (Jaarsma et al., 2014) . Thus, we can speculate that depletion of BICD2 in patients caused the deficit in neuronal cell migration to cortical plate, developing microcephaly phenotype. Golgi fragmentation, disturbed retrograde transport and axonal neurofilament swelling were observed in neurons of transgenic mice model expressing the N-terminal region (Teuling et al., 2008) . BICD2 depletion cause retarded dynein and kinesin dependent movement proving that both retrograde and anterograde trafficking along microtubules essentially requires BICD2 (Neveling et al., 2013; Oates et al., 2013; Peeters et al., 2013) . BICD2 has crucial role in neuronal development. Outgrowth of neurite extensions during neuronal differentiation requires accurate anterograde secretory trafficking (Pfenninger, 2009 ). However, recently it has been demonstrated that different heterozygous mutations in BICD2 irrespective of their position on gene, contribute to the stability of microtubules on motor neurons leading to abnormal axonal branching and reduced neuromuscular junctions (NMJ) justifying the neurological nature of disease (Martinez Carrera et al., 2018) . 
F i r s t A r t i c l e
O n l i n e F i r s t A r t i c l e
So far only few missense mutations in BICD2 with relation to HSP with adult onset have been reported. We report the first nonsense mutation (c.204T>G; p. Glu68*) with severe phenotypic and clinical features and onset by birth. Further quantitative expression analysis and functional exploration of this variant can clearly explain the genotype-phenotype correlation.
CONCLUSION
Genetic exploration of HSP family with complex clinical features revealed a novel nonsense mutation in BICD2 gene. Mutational screening showed that insertion of premature stop codon after 68 amino acids yields extremely truncated protein product. We can speculate that the truncated protein product caused the deficit in normal neuronal development and function. Identification of this novel mutation has increased the mutational spectra of BICD2 gene but further functional exploration is required to develop a phenotype genotype correlation.
O n l i n e F i r s t A r t i c l e
